Fully Funded PhD Opportunities in Advanced Gene and Cell Therapy – MSCA COFUND RAREFIND
Pubblicato il 06-10-2026 - Fondazione Telethon ETS in Italia
Organisation/Company Fondazione Telethon ETS Research Field Biological sciences Chemistry Medical sciences Pharmacological sciences Other Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 31 Dec 2026 - 23:59 (Europe/Rome) Country Italy Type of Contract Temporary Job Status Full-time Offer Starting Date 1 Nov 2027 Is the job funded through the EU Research Framework Programme? Horizon Europe – COFUND Marie Curie Grant Agreement Number Is the Job related to staff position within a Research Infrastructure? No
The fully funded positions focus on experimental research in gene editing and gene therapy , addressing therapeutic applications for inherited retinal diseases, enzymatic deficiency disorders, lysosomal storage disorders, and cancer. Fellows will also engage with cutting-edge approaches, including genome and epigenome editing, miRNA-based therapeutics, vector engineering, and immuno-oncology. Trainees will agevolazioni from a highly collaborative environment and state-of-the-art facilities across the Fondazione Telethon institutes.
- Hold a Master’s degree (or equivalent) in life sciences, medicine, pharmacy, chemistry, or related disciplines.
- Not already hold (or have defended) a doctoral degree.
- Comply with the MSCA mobility rule : applicants must not have lived or carried out their main activities (work, studies) in Italy for more than 12 months in the 36 months immediately before the call deadline.
- Demonstrate strong proficiency in English , both spoken and written.
Languages ENGLISH Level Excellent
Additional Information
- Employment & salary: The gross annual base salary amounts to €32,840, plus any applicable family allowances, in accordance with the rules of the MSCA programme. The amount indicated is gross and is subject to the tax and social security deductions provided for under Italian law.
Tax relief and incentives under Article 44 of Decree Law No. 78/2010 ("Return of Researchers" scheme): Candidates who me